Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

The Relationship Between Clinical Trial Participation and Inhaler Technique Errors in Asthma and COPD Patients

Authors Perumal R, Leite M, van Zyl-Smit RN

Received 13 February 2020

Accepted for publication 20 April 2020

Published 2 June 2020 Volume 2020:15 Pages 1217—1224

DOI https://doi.org/10.2147/COPD.S249620

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Richard Russell


Rubeshan Perumal,1 Marcia Leite,2 Richard Nellis van Zyl-Smit1,2

1Division of Pulmonology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Western Cape, South Africa; 2UCT Lung Institute, University of Cape Town, Western Cape, South Africa

Correspondence: Rubeshan Perumal Email rubeshanperumal@gmail.com

Background: Incorrect inhaler use is associated with poorer health outcomes, reduced quality of life, and higher healthcare utilisation in patients with asthma and COPD.
Methods: We performed an observational study of pressurized metered-dose inhaler technique in patients with asthma or COPD. Patients were assessed using a six-point inhaler checklist to identify common critical inhaler technique errors. An inadequate inhaler technique was defined as the presence of one or more critical errors. A multivariate logistic regression model was used to determine the odds of an inadequate inhaler technique.
Results: During the 14-month study period, 357 patients were enrolled. At least one critical error was executed by 66.7% of participants, and 24.9% made four or more critical errors. The most common errors were failure to exhale completely prior to pMDI activation and inhalation (49.6%), failure to perform a slow, deep inhalation following device activation (48.7%), and failure to perform a breath-hold at the end of inspiration (47.3%). The risk of a critical error was higher in COPD patients (aOR 2.25, 95% CI 1.13– 4.47). Prior training reduced error risk specifically when trained by a doctor (aOR 0.08, 95% CI 0.1– 0.57) or a pharmacist (aOR 0.02, 95% CI 0.01– 0.26) compared to those with no training. Previous clinical trial participation significantly reduced error risk and rate: < 3 trials (aOR 0.35, 95% CI 0.19– 0.66) and ≥ 3 trials (aOR 0.17, 95% CI 0.07– 0.42). The rate of critical errors was not significantly associated with age, sex, or prior pMDI experience.
Conclusion: This study found a high rate of critical inhaler technique errors in a mixed population of asthma and COPD patients; however, prior training and, in particular, multiple previous clinical trial participation significantly reduced the risk of errors.

Keywords: inhaler, pressurised metered-dose inhaler, clinical trials, asthma, COPD

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]